Evommune

Public

Palo Alto, CaliforniaBiotechhttps://www.evommune.com

Evommune is now publicly traded

The data on this page reflects Evommune's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Series C

Oct 31, 2024

Total Funding Raised

$318M

Company Overview

Evommune is a biotechnology company that develops innovative treatments targeting the root causes of inflammatory diseases to enhance patient quality of life.

Sector

Biotech

Verticals

Life Sciences

AI Layer

Non-AI

Keywords

therapies for immune-mediated inflammatory diseasehuman tissue-based drug discovery platformsmall molecule and biologic drug developmentclinical-stage biopharmaceutical pipelinetherapeutics for atopic dermatitistherapeutics for chronic urticariaMRGPRX2 antagonistmast cell-mediated disease therapyIL-18 fusion proteinIRAK4 inhibitorPKCθ inhibitor programRORγt inhibitor program

Evommune Comparables

Compare Evommune with similar companies based on industry and business-model similarity.

Evommune comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Attovia Therapeutics	82%
Jasper Therapeutics	80%
Septerna	80%

View all Comparables

Evommune Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series C	Oct 31, 2024
Series B	Jun 28, 2023
Series B	Mar 28, 2023
Series A	Sep 9, 2021
Seed	Nov 18, 2020

View all Funding Rounds

Evommune Investors

Notable investors and investment history

Evommune investors
Investor	Rounds
Avego Management	Series C
SymBiosis Capital Management	Series C, Series B
ADAR1 Capital Management	Series C
RA Capital Management	Series C
EQT Life Sciences	Series C, Series A, Series B
Amplitude Ventures	Series B, Series C
Andera Partners	Series B, Series C, Series A

View all Investors

Evommune Filings

Explore SEC and related filing metadata, where available.

Evommune filings preview — column headings only; records require access
Type	Date	Amount Offered	Amount Sold	Filing	Pages	Download

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

HeadquartersPalo Alto, California

Employee Range54

Year Founded2020

Last FundingOct 31, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?